Jim A. Julian
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management 49
- Emergency Medical Services top 0.05%
- Central Venous Catheters and Hemodialysis 19
- Hematology top 0.2%
- Blood Coagulation and Thrombosis Mechanisms 16
-
- Atrial Fibrillation Management and Outcomes 22
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 17
-
- Cancer survivorship and care 12
- Global Cancer Incidence and Screening 9
-
- Diagnosis and Treatment of Venous Diseases 11
- Co-authors
- Mark N. LevineMichael GentTimothy J. WhelanAgnes LeeMichael J. KovacsClive KearonMartin H. PrinsChris Bowden
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Jim A. Julian
131 papers receiving 11.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Internal Medicine 5.3k
- Emergency Medical Services 1.8k
- Hematology 2.2k
- Cardiology and Cardiovascular Medicine 3.5k
- Cancer Research 2.3k
Countries citing papers authored by Jim A. Julian
This map shows the geographic impact of Jim A. Julian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim A. Julian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim A. Julian more than expected).
Fields of papers citing papers by Jim A. Julian
This network shows the impact of papers produced by Jim A. Julian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim A. Julian. The network helps show where Jim A. Julian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jim A. Julian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2020 | 1 | |
| 3 | 2020 | 46 | |
| 4 | 2019 | 188 | |
| 5 | 2019 | 33 | |
| 6 | 2019 | 6 | |
| 7 | 2015 | 60 | |
| 8 | 2014 | 2 | |
| 9 | 2014 | 0 | |
| 10 | 2013 | 266 | |
| 11 | Selective D-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis | 2013 | 3 |
| 12 | 2011 | 113 | |
| 13 | 2011 | 246 | |
| 14 | 2011 | 4 | |
| 15 | 2008 | 23 | |
| 16 | 2008 | 15 | |
| 17 | An Evaluation of D-Dimer in the Diagnosis of Pulmonary Embolism | 2006 | 7 |
| 18 | 2005 | 81 | |
| 19 | A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndromebreakdown → | 2003 | 591 |
| 20 | 2003 | 163 |
About Jim A. Julian
Jim A. Julian is a scholar working on Internal Medicine, Emergency Medical Services and Hematology, having authored 132 papers that have together received 12.3k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (49 papers), Atrial Fibrillation Management and Outcomes (22 papers), Central Venous Catheters and Hemodialysis (19 papers), Breast Cancer Treatment Studies (17 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers), Cancer survivorship and care (12 papers), Diagnosis and Treatment of Venous Diseases (11 papers) and Global Cancer Incidence and Screening (9 papers). The work is most often cited by research in Internal Medicine (5.3k citations), Emergency Medical Services (1.8k citations) and Hematology (2.2k citations). Jim A. Julian has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Mark N. Levine, Michael Gent, Timothy J. Whelan, Agnes Lee, Michael J. Kovacs, Clive Kearon, Martin H. Prins, Chris Bowden, Frederick R. Rickles and Ross Baker. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.